Gene transfer for erythropoiesis enhancement

Molecular Medicine Today

Volumn 2, Issue 8, 1996, Pages 343-348

  Naffakh, Nadia ^b   Danos, Olivier ^a  

^a CELL GENESYS INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANIMAL; BETA THALASSEMIA; CELL TRANSPLANTATION; ERYTHROPOIESIS; GENE THERAPY; GENE TRANSFER; GENETICS; HUMAN; METABOLISM; REVIEW;

ANEMIA; ANIMALS; BETA-THALASSEMIA; CELL TRANSPLANTATION; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS;

EID: 0030210492     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-4310(96)81800-4     Document Type: Review

References (30)

1. Adamson, J.W. and Ersbach, J.W. (1990) The use of recombinant human erythropoietin in humans, in Molecular Control of Hemopoiesis (Ciba Foundation Symposium 148) (Bock, G. and Marsh, J., eds), pp. 186-200, John Wiley & sons
2. Koury, M.J. and Bondurant, M.C. (1992) The molecular mechanism of erythropoietin action, Eur. J. Biochem. 210, 649-663
3. Koury, S.T., Bondurant, M.C. and Koury, M.J. (1988) Localization of erythropoietin synthesizing cells in murine kidney by in situ hybridization, Blood 71, 524-527
4. Erslev, A.J. (1991) Erythropoietin. New Engl. J. Med. 324, 1339-1344
5. Karlsson, S. (1991) Treatment of genetic defects in hematopoietic cell function by gene transfer, Blood 78, 2481-2492
6. Villeval, J.L. et al. (1994) Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improves murine β thalassemia, Blood 84, 928-933
7. Skow, L.C., Burkhart, B.A. and Johnson, F.M. (1983) A mouse model for β thalassemia, Cell 34, 1043-1052
8. Naffakh, N. et al. (1995) Sustained delivery of erythtropoietin in mice by autologous implants of genetically-modified skin fibroblasts, Proc. Natl. Acad. Sci. U. S. A. 92, 3194-3198
9. Hamamori, Y., Samal, B., Tian, J. and Kedes, L. (1994) Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA, Hum. Gene Ther. 5, 1349-1356
10. Naffakh, N. et al. (1996) Long-term secretion of therapeutic proteins from genetically-modified skeletal muscles, Hum. Gene Ther. 7, 11-21
11. Osborne, W.A. et al. (1995) Gene therapy for long-term expression of erythropoietin in rats, Proc. Natl. Acad. Sci. U. S. A. 92, 8055-8058
12. Descamps, V. et al. (1995) Organoids direct systemic expression of erythropoietin in mice, Gene Ther. 2, 411-417
13. Clowes, M.M. et al. (1994) Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes, J. Clin. Invest. 93, 644-651
14. Hamamori, Y., Samal, B., Tian, J. and Kedes, L. (1995) Myoblast transfer of human erythropoietin gene in a mouse model of renal failure, J. Clin. Invest. 95, 1808-1813
15. Moullier, P. et al. (1995) Long term delivery of lysosomal enzyme by genetically-modified fibroblasts in dogs, Nat. Med. 1, 353-358
16. Yang, Y. et al. (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U. S. A. 91, 4407-4411
17. Tripathy, S.K. et al. (1994) Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus, Proc. Natl. Acad. Sci. U. S. A. 91, 11557-11561
18. Setoguchi, Y., Danel, C. and Crystal, R.J. (1994) Stimulation of erythropoiesis by in vivo gene therapy: physiologic consequences of transfer of the human erythropoietin gene using an adenovirus vector, Blood 84, 2946-2953
19. Tripathy, S.K., Black, H.B., Goldwasser, E. and Leiden, J.M. (1996) Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors, Nat. Med. 2, 545-550
20. Descamps, V. et al. (1994) Erythropoietin gene transfer and expression in adult normal mice: use of an adenovirus vector, Hum. Gene Ther. 5, 979-985
21. Barr, D. et al. (1995) Strain related variations in adenovirally-mediated transgene expression from mouse hepatocytes in vivo: comparison between immunocompetent and immunodeficient inbred strains, Gene Ther. 2, 151-155
22. Scharfmann, R., Axelrod, J.H. and Verma, I.M. (1991) Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants, Proc. Natl. Acad. Sci. U. S. A. 88, 4626-4630
23. Pugh, B.F. and Tjian, R. (1991) Transcription from a TATA-less promoter requires a multisubunit TFIID complex, Genes Dev. 5, 1935-1945
24. Villeval, J.L., Metcalf, D. and Johnson, G.R. (1992) Fatal polycythemia induced in mice by dysregulated erythropoietin production by hematopoietic cells, Leukemia 6, 107-115
25. McDonald, T.P., Clift, R.E. and Cottrel, M.B. (1992) Large, chronic doses of erythropoietin cause thrombocytopenia in mice, Blood 80, 352-358
26. Garcia, D.L., Anderson, S., Rennke, H. and Brener, B.M. (1988) Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass, Proc. Natl. Acad. Sci. U. S. A. 85, 6142-6146
27. Madan, A. and Curtin, P.T. (1993) A 24-base-pair sequence 3′ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer, Proc. Natl. Acad. Sci. U. S. A. 90, 3928-3932
28. Wang, G.L. and Semenza, G.L. (1993) General involvment of hypoxia-inducible factor 1 in transcriptional response to hypoxia, Proc. Natl. Acad. Sci. U. S. A. 90, 4304-4308
29. Madan, A., Lin, C., Hatch, S.L., II and Curtin, P.T. (1995) Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences, Blood 85, 2735-2741
30. Gossen, M. et al. (1995) Transcriptional activation by tetracyclines in mammalian cells, Science 268, 1766-1769